SkinMedica Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SkinMedica Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014325
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SkinMedica Inc (SkinMedica) is a manufacturer and distributor of skin care products. The company’s products include purifying foaming wash, facial cleanser, skin polisher, purifying toner, TNS recovery complex, uplifting eye serum, restorative ointment, dermal repair cream, and post procedure system, among others. It provides gels for the treatment of mild to moderate atopic dermatitis creams for the reduction in growth of unwanted facial hair in women. SkinMedica offers products for treatment of hyper pigmentation. The company markets its products through physicians’ offices and online. SkinMedica is headquartered in Carlsbad, California, the US.

SkinMedica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SkinMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SkinMedica Inc, Medical Devices Deals, 2011 to YTD 2017 9
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SkinMedica Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Colorescience Raises USD15 Million in Series B Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 12
Colorescience Raises US$15 Million In Venture Financing 13
SkinMedica Raises US$16.8 Million In Venture Financing 14
Private Equity 15
VMG Partners Invests In Colorescience 15
Partnerships 16
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 16
Acquisition 17
Allergan Completes Acquisition Of SkinMedica, Skin Products Maker, For US$350 Million 17
SkinMedica Acquires Colorescience, Maker Of Skincare Products 19
SkinMedica Inc – Key Competitors 20
SkinMedica Inc – Key Employees 21
SkinMedica Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
SkinMedica Inc, Pharmaceuticals & Healthcare, Key Facts 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SkinMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SkinMedica Inc, Deals By Therapy Area, 2011 to YTD 2017 8
SkinMedica Inc, Medical Devices Deals, 2011 to YTD 2017 9
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Colorescience Raises USD15 Million in Series B Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 12
Colorescience Raises US$15 Million In Venture Financing 13
SkinMedica Raises US$16.8 Million In Venture Financing 14
VMG Partners Invests In Colorescience 15
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 16
Allergan Completes Acquisition Of SkinMedica, Skin Products Maker, For US$350 Million 17
SkinMedica Acquires Colorescience, Maker Of Skincare Products 19
SkinMedica Inc, Key Competitors 20
SkinMedica Inc, Key Employees 21
SkinMedica Inc, Subsidiaries 22

★海外企業調査レポート[SkinMedica Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Iluka Resources Ltd:企業の戦略・SWOT・財務情報
    Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Regal Petroleum plc (RPT):企業の財務・戦略的SWOT分析
    Summary Regal Petroleum Plc (Regal), a subsidiary of Energees Investments Ltd, is an oil and gas company that conducts reviews on oil and gas projects. The company operates two gas and condensate fields such as Mekhediviska - Golotovschinska and Svyrydivske located in Dneipner-Donets basin in the no …
  • Nuverra Environmental Solutions Inc (NES):企業の財務・戦略的SWOT分析
    Nuverra Environmental Solutions Inc (NES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • 3D Signatures Inc (DXD):医療機器:M&Aディール及び事業提携情報
    Summary 3D Signatures Inc (3D Signatures) is a developer of diagnostic and prognostic products for cancers and neurological disorders. The company's pipeline products include 3D Telo-PC a tool that is used to treat prostate cancer. It also provides 3D Telo-RS a diagnostic and prognostic tool used fo …
  • Kepler Weber S.A. (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bentley Systems Incorporated:企業のM&A・事業提携・投資動向
    Bentley Systems Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bentley Systems Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Contango Oil & Gas Co (MCF):企業の財務・戦略的SWOT分析
    Summary Contango Oil & Gas Co (Contango) is an oil and natural gas company that explores, exploits, develops, produces and acquires crude oil and natural gas properties. The company provides operation for both offshore and onshore producing assets. Its offshore operations comprise Vermilion 170 plat …
  • Young Innovations Inc:企業の戦略的SWOT分析
    Young Innovations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Genmab AS (GMAB):企業の財務・戦略的SWOT分析
    Genmab AS (GMAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. The company manufactures and markets high performance polymers and specialty chemicals. Its products include bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie …
  • Taisho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products that include lipovitan D, riup, clari …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Atlantic Airways P/F:企業の戦略・SWOT・財務情報
    Atlantic Airways P/F - Strategy, SWOT and Corporate Finance Report Summary Atlantic Airways P/F - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bank of America Corporation:企業のM&A・事業提携・投資動向
    Bank of America Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of America Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Direct Energie SA (DIREN):企業の財務・戦略的SWOT分析
    Summary Direct Energie SA (Direct Energie), formerly Poweo Direct Energie SA, a subsidiary of Total SA, is a power company that generates and distributes electricity and natural gas. The company's services include construction of combined cycle gas, electrical repair services, technical services, an …
  • Hotel Grand Central Limited:企業の戦略・SWOT・財務情報
    Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Oxford Immunotec Ltd:企業の製品パイプライン分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Akamai Technologies Inc (AKAM):企業の財務・戦略的SWOT分析
    Akamai Technologies Inc (AKAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • UCB SA (UCB)-医療機器分野:企業M&A・提携分析
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Titan Machinery Inc (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆